rosiglitazone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Huang, F; Li, Y; Zhang, XK; Zhou, H | 1 |
1 other study(ies) available for rosiglitazone and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
Rosiglitazone binds to RXRα to induce RXRα tetramerization and NB4 cell differentiation.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; HEK293 Cells; Humans; Hypoglycemic Agents; Leukemia, Promyelocytic, Acute; Protein Multimerization; Retinoid X Receptor alpha; Rosiglitazone | 2020 |